Page last updated: 2024-10-26

dipyridamole and Erythermalgia

dipyridamole has been researched along with Erythermalgia in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Healsmith, MF1
Graham-Brown, RA1
Burns, DA1

Reviews

1 review available for dipyridamole and Erythermalgia

ArticleYear
Erythromelalgia.
    Clinical and experimental dermatology, 1991, Volume: 16, Issue:1

    Topics: Aspirin; Dipyridamole; Erythromelalgia; Female; Humans; Middle Aged; Propranolol

1991